New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
Immunology & Rheumatology April 10,2024
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
Immunology & Rheumatology April 10,2024
COVID-19 virus helps block host immunity

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc
Immunology & Rheumatology April 10,2024
COVID-19 virus helps block host immunity

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc
Immunology & Rheumatology April 10,2024
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese
Immunology & Rheumatology April 10,2024
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset

by Instituto de Medicina MolecularColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19. Credit: NIAID Integrated Rese
Immunology & Rheumatology April 10,2024
COVID-19 science: Understanding the basics of 'herd immunity'

COVID-19 science: Understanding the basics of 'herd immunity'

by Dr. Eduardo Sanchez,American Heart AssociationCredit: CC0 Public DomainRecently I heard a medical "expert" on the news incorrectly define the term "herd immunity." It'
Immunology & Rheumatology April 10,2024
COVID-19 science: Understanding the basics of 'herd immunity'

COVID-19 science: Understanding the basics of 'herd immunity'

by Dr. Eduardo Sanchez,American Heart AssociationCredit: CC0 Public DomainRecently I heard a medical "expert" on the news incorrectly define the term "herd immunity." It'
Immunology & Rheumatology April 10,2024
COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain
Immunology & Rheumatology April 10,2024
COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain
Immunology & Rheumatology April 10,2024
Immune cell responses in COVID-19 patients far from optimal

Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present
Immunology & Rheumatology April 10,2024
Immune cell responses in COVID-19 patients far from optimal

Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present
Immunology & Rheumatology April 10,2024
COVID-19 can cause severe inflammation in the brain

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa
Immunology & Rheumatology April 10,2024
COVID-19 can cause severe inflammation in the brain

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa
Immunology & Rheumatology April 10,2024
COVID-19's deadliness for men reveals why researchers should have been studying immune system sex differences years ago

COVID-19's deadliness for men reveals why researchers should have been studying immune system sex differences years ago

by Adam Moeser,The ConversationCredit: CC0 Public DomainWhen it comes to surviving critical cases of COVID-19, it appears that men draw the short straw.Initial reports from China revealed the ea
Immunology & Rheumatology April 10,2024
COVID-19's deadliness for men reveals why researchers should have been studying immune system sex differences years ago

COVID-19's deadliness for men reveals why researchers should have been studying immune system sex differences years ago

by Adam Moeser,The ConversationCredit: CC0 Public DomainWhen it comes to surviving critical cases of COVID-19, it appears that men draw the short straw.Initial reports from China revealed the ea
Immunology & Rheumatology April 10,2024
COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

by Maria Fernanda Ziegler,FAPESPThe systems immunology approach identifies an aging effect on autoantibody levels of COVID-19 patients. Credit:npj Aging(2023). DOI: 10.1038/s41514-02
Immunology & Rheumatology April 10,2024
COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

by Maria Fernanda Ziegler,FAPESPThe systems immunology approach identifies an aging effect on autoantibody levels of COVID-19 patients. Credit:npj Aging(2023). DOI: 10.1038/s41514-02
Immunology & Rheumatology April 10,2024
How a COVID-19 infection spurs antibodies against common colds

How a COVID-19 infection spurs antibodies against common colds

by The Scripps Research InstituteResearchers analyzed the structures of antibodies (colored) from healthy donors as the molecules bound to the spike protein from common coronaviruses like OC43 (s
Immunology & Rheumatology April 10,2024
How a COVID-19 infection spurs antibodies against common colds

How a COVID-19 infection spurs antibodies against common colds

by The Scripps Research InstituteResearchers analyzed the structures of antibodies (colored) from healthy donors as the molecules bound to the spike protein from common coronaviruses like OC43 (s
Immunology & Rheumatology April 10,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com